R4 Draft for Comment

This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationrequest0306.xml

Pharmacy Work GroupMaturity Level: N/ABallot Status: InformativeCompartments: Encounter, Patient, Practitioner

Raw XML (canonical form)

Jump past Narrative

Oral Chemotherapy Order - Myleran - completed - with reasonCode (id = "medrx0306")

<MedicationRequest xmlns="http://hl7.org/fhir">
    <id value="medrx0306"/> 
    <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : medrx0306</p> <p> <b> contained</b> : </p> <p> <b> identifier</b> : 12345689 (OFFICIAL)</p> <p> <b> status</b> : active</p> <p> <b> intent</b> : order</p> <p> <b> medication</b> : Myleran 2mg tablet. Generated Summary: id: med0304; Myleran 2mg tablet, film coated
         <span> (Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = '76388-713-25', given as
           'Myleran 2mg tablet, film coated'})</span> </p> <p> <b> subject</b> : <a> Donald Duck</a> </p> <p> <b> authoredOn</b> : 15/01/2015</p> <p> <b> requester</b> : <a> Patrick Pump</a> </p> <p> <b> reasonCode</b> : Chronic myeloid Leukemia (disorder) <span> (Details : {SNOMED CT code '92818009' = 'Chronic myeloid leukemia', given as 'Chronic
           myeloid Leukemia (disorder)'})</span> </p> <p> <b> dosageInstruction</b> : </p> </div> </text> <contained> 
        <Medication> 
            <id value="med0304"/> 
            <code> 
                <coding> 
                    <system value="http://hl7.org/fhir/sid/ndc"/> 
                    <code value="76388-713-25"/> 
                    <display value="Myleran 2mg tablet, film coated"/> 
                </coding> 
            </code> 
        </Medication> 
    </contained> 
    <identifier> 
        <use value="official"/> 
        <system value="http://www.bmc.nl/portal/prescriptions"/> 
        <value value="12345689"/> 
    </identifier> 
    <status value="active"/> 
    <intent value="order">
    </intent> 
    <medicationReference> 
        <reference value="#med0304"/> 
        <display value="Myleran 2mg tablet"/> 
    </medicationReference> 
    <subject> 
        <!--    Linked to the resource patient who needs the medication    -->
        <reference value="Patient/pat1"/> 
        <display value="Donald Duck"/>    
    </subject> 
    <authoredOn value="2015-01-15"/> 
    <requester> 
        <!--    Linked to the practitioner who treats patient    -->
        <reference value="Practitioner/f007"/> 
        <display value="Patrick Pump"/> 
        </requester> 
    <reasonCode> 
        <coding> 
            <system value="http://snomed.info/sct"/> 
            <code value="92818009"/> 
            <display value="Chronic myeloid Leukemia (disorder)"/> 
        </coding> 
    </reasonCode> 
    <dosageInstruction> 
        <sequence value="1"/> 
        <text value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.
      With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL"/> 
        <timing> 
            <repeat> 
                <frequency value="1"/> 
                <period value="1"/> 
                <periodUnit value="d"/> 
            </repeat> 
        </timing> 
        <route> 
            <coding> 
                <system value="http://snomed.info/sct"/> 
                <code value="26643006"/> 
                <display value="Oral route (qualifier value)"/> 
            </coding> 
        </route> 
        <doseQuantity> 
            <value value="6"/> 
            <unit value="mg"/> 
            <system value="http://unitsofmeasure.org"/> 
            <code value="mg"/> 
        </doseQuantity> 
    </dosageInstruction> 
</MedicationRequest> 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.